Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Security

Accelerant Holdings · ARX

ARXNYSECommon stockCurrentCIK 1997350Updated Oct 4, 2026

Company: Accelerant Holdings →

ARX price & chart

Provider market data

Loading TradingView…

NYSE:ARX on TradingView ↗

TradingView · Data may be delayed

About the company

Accelerant was founded in 2018 by three industry veterans with over 100 years of collective experience in the insurance and reinsurance industries. They experienced first-hand the structural inefficiencies and fragmentation of the insurance market. There were too many intermediaries operating across siloed entities, resulting in a lack of customer prioritization and excess costs. Antiquated technology, poor data quality, and insufficient transparency has led to information asymmetries, inaccurate pricing, misaligned incentives, and inconsistent capital availability. Our founders were determined to build a platform to solve these issues. By democratizing data and aligning incentives in a single platform, Accelerant strives to deliver better outcomes for all Risk Exchange participants.

424B4 · 2025-07-25 · 0001193125-25-164549

Company description from the cited filing.

In the news

Seeking Alpha
SEC disclosures

Recent filings

  1. SCHEDULE 13G - filed by GLAZER CAPITAL, LLC regarding Accelerant Holdings

    SCHEDULE 13G · 2026-09-30 · 0001076809-26-000110

  2. Other Events

    Items 8.01, 9.01

    8-K · 2026-09-23 · 0001997350-26-000018

  3. 144 filing

    144 · 2026-08-21 · 0001950047-26-008508

  4. 4 filing

    4 · 2026-08-14 · 0001628280-26-057158

  5. DEFA14A filing

    DEFA14A · 2026-08-14 · 0001193125-26-349978

Show 5 more recent filings
  1. Entry into a Material Definitive Agreement

    Items 1.01, 9.01

    8-K · 2026-08-14 · 0001193125-26-349973

  2. DEFA14A filing

    DEFA14A · 2026-08-14 · 0001193125-26-349966

  3. DEFA14A filing

    DEFA14A · 2026-08-13 · 0001193125-26-349655

  4. 144 filing

    144 · 2026-08-13 · 0001950047-26-008098

  5. 10-Q filing

    10-Q · 2026-08-13 · 0001997350-26-000015

Financials

FY 2025 · USD
Revenue912,900,000USD · FY 2025
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

Net income— · FY 2025
Operating income— · FY 2025
Diluted EPS-7.49USD per share · FY 2025
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025FY 2024
ASSETS
AssetsUSD8,263,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

6,094,900,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

GoodwillUSD63,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

30,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2024-12-31

Intangible Assets, Net (Excluding Goodwill)USD52,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

33,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2024-12-31

Current assets:
Cash and Cash Equivalents, at Carrying ValueUSD1,716,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

1,225,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2024-12-31

LIABILITIES AND EQUITY
LiabilitiesUSD7,536,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

5,667,900,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Stockholders’ equity:
Common Stock, Value, IssuedUSD0
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

0
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Additional Paid in CapitalUSD2,232,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

124,800,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Retained Earnings (Accumulated Deficit)USD-1,536,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

-182,800,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD2,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

-19,500,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Stockholders' Equity Attributable to ParentUSD697,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

304,300,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Liabilities and EquityUSD8,263,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

6,094,900,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Stockholders' Equity Attributable to Noncontrolling InterestUSD28,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

18,300,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Additional Financial Items
Long-term DebtUSD121,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

121,400,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025FY 2024
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD-1,345,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

22,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization——
Share-based Payment Arrangement, Noncash ExpenseUSD43,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

8,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Deferred Income Tax Expense (Benefit)USD-32,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

-40,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Net Cash Provided by (Used in) Operating ActivitiesUSD445,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

785,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Cash flows from investing activities:
Payments to Acquire Businesses, Net of Cash AcquiredUSD9,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Net Cash Provided by (Used in) Investing ActivitiesUSD-173,600,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

-380,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Payments for (Proceeds from) Other Investing ActivitiesUSD500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

1,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD205,800,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

110,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Repayments of Long-term DebtUSD5,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

0
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD1,799,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

1,273,000,000
Source

10-Q · 2025-08-28 · 0001997350-25-000004

As of 2024-12-31

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD10,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

11,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Income Taxes Paid, NetUSD59,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

45,500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Additional Financial Items
Share-based Payment Arrangement, ExpenseUSD53,600,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

8,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Amortization of Intangible AssetsUSD5,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

2,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Debt Securities, Available-for-sale, Realized Gain (Loss)USD2,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Deferred Policy Acquisition Costs, Amortization ExpenseUSD80,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

81,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Equity Method Investment, Realized Gain (Loss) on DisposalUSD2,500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

1,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Equity Securities, FV-NI, Realized Gain (Loss)USD0
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Equity Securities, FV-NI, Unrealized Gain (Loss)USD0
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

-800,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

—
Foreign Currency Transaction Gain (Loss), before TaxUSD-20,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

5,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Gain (Loss) on InvestmentsUSD47,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

20,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

General and Administrative ExpenseUSD400,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

249,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

GoodwillUSD63,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2025-12-31

30,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

As of 2024-12-31

Impairment of Intangible Assets, Finite-livedUSD0
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

0
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Income (Loss) from Equity Method InvestmentsUSD1,800,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

2,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Income Tax Expense (Benefit)USD23,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

9,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD204,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

167,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD8,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

-4,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD-1,425,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

27,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Proceeds from Issuance of Common StockUSD392,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

0
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD49,800,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

18,600,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Realized Investment Gains (Losses)USD7,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

1,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Unrealized Gain (Loss) on InvestmentsUSD39,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

19,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024
Total RevenueUSD912,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

602,600,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD-1,321,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

32,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Income Tax Expense (Benefit)USD23,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

9,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Net Income (Loss) Attributable to Noncontrolling InterestUSD8,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

-4,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Earnings Per Share, BasicUSD per share-7.49
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

0.16
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Earnings Per Share, DilutedUSD per share-7.49
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

0.14
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Weighted Average Number of Shares Outstanding, Basicshares190,260,158
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

165,982,094
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares190,260,158
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

199,663,694
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Additional Financial Items
Amortization of Intangible AssetsUSD5,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

2,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Benefits, Losses and ExpensesUSD2,234,800,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

570,600,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Current Income Tax Expense (Benefit)USD55,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

50,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Deferred Policy Acquisition Costs, Amortization ExpenseUSD80,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

81,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Depreciation, Depletion and Amortization, NonproductionUSD35,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

26,600,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Equity Securities, FV-NI, Realized Gain (Loss)USD0
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual AmountUSD500,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

—
Foreign Currency Transaction Gain (Loss), before TaxUSD-20,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

5,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Gain (Loss) on InvestmentsUSD47,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

20,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

General and Administrative ExpenseUSD400,400,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

249,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD-1,411,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

45,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Income (Loss) from Equity Method InvestmentsUSD1,800,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

2,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Interest Expense, DebtUSD10,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

12,100,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD204,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

167,300,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Net Income (Loss) Available to Common Stockholders, BasicUSD-1,425,000,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

27,200,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Net Investment IncomeUSD48,700,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

38,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Realized Investment Gains (Losses)USD7,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2025-01-01 to 2025-12-31

1,900,000
Source

10-K · 2026-03-18 · 0001997350-26-000003

2024-01-01 to 2024-12-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-288435

424B4 · 2025-07-25 · 0001193125-25-164549

Terms from the governing filing for this registration; not a claim that the offering is open today.

Gross proceeds
723684192.0
Net proceeds
402382777.0
Deal price
21.0
Shares
34461152
Offering amount
$723,684,192
Offering price
$21.00
Ticker
ARX

Filing attachments

ex991-pressreleaseendofgox.htm · 8-K · 2026-09-23

Exhibit 99.1 Accelerant Announces Expiration of “Go-Shop” Period ATLANTA - (BUSINESS WIRE) - Accelerant Holdings (NYSE: ARX) (“Accelerant”), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced the expiration of the 40-day “go-shop” period under the terms of the previously announced definitive merger agreement entered into by Accelerant on August 13, 2026, pursuant to which affiliates of Thoma Bravo will a…

8-K · 2026-09-23 · 0001997350-26-000018

Read attachment ↗
d286225dex991.htm · 8-K · 2026-08-13

EX-99.1 2 d286225dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Accelerant Announces Second Quarter 2026 Results Accelerant Cancels Earnings Conference Call Following Announcement of Agreement with Thoma Bravo to Become a Private Company Second Quarter 2026 Results Exchange Written Premium of $1.32 billion grew 23% year-over-year Third-Party Direct Written Premium accounted for 47% of Exchange Written Premium volume ───────────────────────────────────────────────────────────────────────…

8-K · 2026-08-13 · 0001193125-26-347925

Read attachment ↗
d286225dex992.htm · 8-K · 2026-08-13

EX-99.2 3 d286225dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Accelerant Enters into Definitive Agreement to be Acquired by Thoma Bravo Accelerant Shareholders to Receive $20.25 per Share in Cash, Representing a 49% Premium to Accelerant’s Closing Share Price on August 12, 2026 August 13, 2026 - Accelerant (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced that it has entered into a defini…

8-K · 2026-08-13 · 0001193125-26-347925

Read attachment ↗
d143863dex991.htm · 8-K · 2026-05-29

EX-99.1 2 d143863dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Accelerant to Present at William Blair’s 46th Annual Growth Stock Conference May 29, 2026 ATLANTA - (BUSINESS WIRE) - Accelerant (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced Jeff Radke, Chairman and Chief Executive Officer, will be presenting at the William Blair Growth Stock Conference on Wednesday, June 3, 2026 at 10:20 a…

8-K · 2026-05-29 · 0001193125-26-246424

Read attachment ↗
d80009dex991.htm · 8-K · 2026-03-18

EX-99.1 5 d80009dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Accelerant Announces Fourth Quarter and Full Year 2025 Results Fourth Quarter & Full Year 2025 Results Exchange Written Premium of $1.09 billion grew 24% year-over-year during the fourth quarter and 35% for the full year 2025 Third-Party Direct Written Premium accounted for 40% of Exchange Written Premium volume, up from 21% in the prior year quarter ─────────────────────────────────────────────────────────────────────────…

8-K · 2026-03-18 · 0001193125-26-113962

Read attachment ↗
d80009dex992.htm · 8-K · 2026-03-18

EX-99.2 6 d80009dex992.htm EX-99.2 EX-99.2 Exhibit 99.2 Accelerant: The Global Specialty Insurance Risk Exchange March 2026 Legal Disclaimer Forward-Looking Statements All statements in this presentation that are not historical are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks and uncertainties. Accelerant Holdings (“we” or “our”) generally identifies forward- looking statements by use of forward-lookin…

8-K · 2026-03-18 · 0001193125-26-113962

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.